Rhythm Biosciences Limited
Medical and Diagnostic LaboratoriesAustralia11-50 Employees
Rhythm Biosciences Limited is an Australian publicly listed medical diagnostics company focused on developing simple, affordable blood tests to enable early cancer detection and provide clinicians with reliable diagnostic tools. Its first test, ColoSTAT, targets colorectal cancer and is intended as an alternative screening option for individuals who cannot or prefer not to use current modalities. The company aims to make early detection more accessible and to support clinicians in making timely, accurate diagnoses, with a strategy centered on partnerships to commercialize its solutions. Based in Australia and operating in the medical and diagnostic laboratories sector, Rhythm pursues collaborations with global partners to bring its tests to market. A notable development in early 2026 was a manufacturing partnership with Quansys Biosciences to advance ColoSTAT’s production, reflecting progress in scaling its colorectal cancer screening solution.